Press-release for stocks in the health technology sector

Prices are updated after-hours

sector : Health technology crawled date : 2021 - 07 - 27

save search

Nektar to Announce Financial Results for the Second Quarter 2021 on Thursday, August 5, 2021, After Close of U.S.-Based Financial Markets
Published: 2021-07-27 (Crawled : 23:00) - prnewswire.com
NKTR | News | $1.3 -3.7% -3.85% 3.6M

Health Technology

| -91.51% | O: 0.13% H: 2.39% C: 2.01%
financial results results

Global General Purpose Test Equipment (GPTE) Market | $ 1.42 Billion Growth Expected During 2021-2025 | Technavio
Published: 2021-07-27 (Crawled : 23:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M

Health Technology

| 3.2% | O: -2.32% H: 2.16% C: 1.98%
KEYS | $146.89 -2.03% 0.0% 1.1M

Electronic Technology

| -5.61% | O: 0.27% H: 1.21% C: 0.55%
test growth gpt-3

Cytek Biosciences Announces Closing of Its Initial Public Offering
Published: 2021-07-27 (Crawled : 23:00) - globenewswire.com
CTKB S | $5.97 0.85% 0.84% 670K

Health Technology

| -65.92% | O: 0.91% H: 15.33% C: 12.27%
MS | News | $90.26 0.2% 0.0% 6.7M

Finance

| -6.42% | O: 0.03% H: 0.39% C: -0.46%
offering bioscience publication

Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021Management to host conference call and webcast at 8:30 AM ET on that day
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
NNOX | $9.09 -2.78% -2.86% 810K

Health Technology

| -66.18% | O: -1.37% H: 2.64% C: 1.72%
results conference

Clinical Utility of ALK Fusion Detection by Liquid Biopsy
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
A | $132.44 -1.57% -0.36% 1.9M

Health Technology

| -8.95% | O: -0.64% H: 0.48% C: 0.44%

Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
ZLAB | $14.2 3.5% 3.38% 690K

Health Technology

| -89.56% | O: -5.31% H: 0.35% C: -6.83%
ETTX | $2.19 -0.46% 0.46%

Health Technology

| -8.16% | O: 0.42% H: 0.0% C: -3.54%
phase 3 trial enroll

Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -10.69% | O: -0.54% H: 0.65% C: 0.49%
CAPR | $5.055 -8.92% -9.79% 940K

Health Technology

| 24.06% | O: 0.42% H: 0.05% C: -3.33%

SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
SWTX | $42.48 -3.7% -3.84% 810K

Health Technology

| -47.93% | O: -0.4% H: 1.84% C: 0.21%
therapeutics

AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
ACIU | $2.43 0.41% 0.41% 370K

Health Technology

| -65.59% | O: 1.83% H: 2.76% C: -1.24%
disease neurodegenerative immunotherapy therapy alpha-synuclein

Lantern Pharma Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (LP-100) from Allarity Therapeutics A/S
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
LTRN | $5.87 -2.0% -2.04% 110K

Health Technology

| -53.28% | O: 0.62% H: 1.32% C: -2.48%
phase 2 commercialization prostate cancer cancer trial

Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M

Health Technology

| -99.28% | O: -25.68% H: 4.24% C: -7.88%
phase 2 cancer breast cancer trial

Kronos Bio Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia (AML)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
KRON | $1.01 -2.89% -2.97% 210K

Health Technology

| -95.05% | O: 1.29% H: 0.0% C: -2.49%
new drug fda clearance treatment fda myeloid leukemia drug leukemia clearance acute myeloid leukemia aml

Aspira Women’s Health Inc. to Report Second Quarter 2021 Financial Results on August 12
Published: 2021-07-27 (Crawled : 21:00) - vermillion.com
AWH | $3.515 0.72% 0.71% 7.8K

Health Technology

| -26.75% | O: -0.21% H: 4.04% C: 0.85%
financial results women results health

Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ALLO | $3.455 -1.57% -1.59% 1.2M

Health Technology

| -83.87% | O: -0.69% H: 2.04% C: 0.28%
financial results results conference

Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ABBV | $164.66 0.25% -0.15% 4.5M

Health Technology

| 39.17% | O: 0.0% H: 0.43% C: 0.14%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 8.92% | O: -0.39% H: 0.61% C: 0.23%
milestone

Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
SRDX | $26.37 -0.57% -0.57% 140K

Health Technology

| -51.38% | O: -0.02% H: 0.0% C: -1.03%
conference

I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K

Health Technology

| -97.12% | O: -3.42% H: 1.32% C: -0.13%
potential

544SM, Associate Scientist / Senior Research Associate, Bioassay Development
Published: 2021-07-27 (Crawled : 21:00) - fatetherapeutics.com
FATE | $5.04 -4.36% -4.56% 2.3M

Health Technology

| -93.29% | O: 0.22% H: 5.73% C: 5.6%
research

Zealand Pharma A/S – Final Transactions Under Share Repurchase Program
Published: 2021-07-27 (Crawled : 21:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology